(Press-News.org) Washington, DC—A new international study finds that prolonged, intense initial treatment in children with multi-system Langerhans cell histiocytosis (MS-LCH) can achieve survival rates as high as 84 percent—a full 15 percent improvement over the previous clinical trial in this series.
The study, LCH-III, is published in Blood, the journal of the American Society of Hematology. It is the third in a series of international randomized clinical trials for LCH that spans twenty years initiated and coordinated by the Histiocyte Society, a group of more than 200 physicians and scientists worldwide. The LCH clinical trial series are the first randomized clinical trials for the treatment of LCH.
Langerhans cells are found throughout the body and help regulate the immune system. In LCH, the cells proliferate excessively in a single organ or in multiple organ systems, damaging surrounding tissue and producing a wide range of symptoms. LCH occurs most often in children and its cause is unknown. In the most serious cases, LCH affects "risk organs," such as the liver or lungs, and can be fatal.
In this study, high-risk patients received one or two six-week courses of chemotherapy, followed by milder continuation therapy in those who responded to the initial course—for a combined 12 months of treatment. The overall five-year survival probability for these patients was 84 percent—substantially higher than in the two preceding trials (62 percent for LCH-I and 69 percent for LCH-II), in which patients were treated for six months. Moreover, the five-year risk of disease reactivation was much lower (27 percent) than in comparable patients in the two earlier trials.
Lower-risk patients in this study who responded after an initial six-week course of treatment were randomly assigned to receive six or 12 months' total treatment. The longer 12-month treatment significantly decreased the disease reactivation rate (37 percent), compared to the six-month treatment group (54 percent).
The study authors note that the first 12 weeks of treatment seem to be a critical time for patient outcomes with MS-LCH and that "aggressive salvage therapy was quite effective in patients not responding to the protocol therapy"—achieving a survival rate of 75 percent.
"These findings are real cause for hope for children with multi-system LCH, now that we have achieved improved survival rates in these three sequential studies," said senior author Stephan Ladisch, MD, a researcher in the Center for Cancer and Immunology Research at the Children's Research Institute and Professor of Pediatrics and Biochemistry/Molecular Biology at Children's National Medical Center. "The international collaboration in these trials has been essential to making significant progress against such a rare disorder, and children around the world will benefit from this research."
Results of the first LCH clinical trial were published in 2001 in the Journal of Pediatrics. Findings from the second trial were published in Blood in 2008. Goals for future trials include reduction of the remaining 15 percent mortality among patients with risk-organ involvement and reduction of the 30-40 percent disease reactivation rate.
###
Contact: Emily Hartman or Paula Darte, 202-476-4500
About Children's National Medical Center
Children's National Medical Center in Washington, DC, has been serving the nation's children since 1870. Home to Children's Research Institute and the Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National is consistently ranked among the top pediatric hospitals by U.S.News & World Report and the Leapfrog Group. Children's National is a Magnet® designated hospital. With 303 beds and eight regional outpatient centers, Children's National is the premier provider of acute pediatric services in the Washington metropolitan area. For more information, visit ChildrensNational.org, or follow us on Facebook and Twitter.
Study shows longer treatment for children with langerhans cell hystiocytosis improves survival rates
2013-05-29
ELSE PRESS RELEASES FROM THIS DATE:
Twitter may become less interactive and more an advertising broadcast medium like TV or radio
2013-05-29
PITTSBURGH—Popular social media site Twitter may eventually resemble a broadcast medium like television or radio, with users reading messages written by celebrities and corporations rather than writing their own "tweet" messages of up to 140 characters, suggests a new study coauthored by Andrew T. Stephen, assistant professor of business administration and Katz Fellow in Marketing in the University of Pittsburgh's Joseph M. Katz Graduate School of Business and College of Business Administration.
In one of the first studies to use social media as a laboratory for social ...
People can 'beat' guilt detection tests by suppressing incriminating memories
2013-05-29
New research published by an international team of psychologists has shown that people can suppress incriminating memories and thereby avoid detection in brain activity guilt detection tests.
Such tests, which are commercially available in the USA and are used by law enforcement agencies in several countries, including Japan and India, are based on the logic that criminals will have specific memories of their crime stored in their brain. Once presented with reminders of their crime in a guilt detection test, it is assumed that their brain will automatically and uncontrollably ...
Pigeons peck for computerized treat
2013-05-29
Go to about any public square, and you see pigeons pecking at the ground, always in search of crumbs dropped by a passerby. While the pigeons' scavenging may seem random, new research by psychologists at the University of Iowa suggest the birds are capable of making highly intelligent choices, sometimes with problem-solving skills to match.
The study by Edward Wasserman and colleagues centered on the "string task," a longstanding, standard test of intelligence that involves attaching a treat to one of two strings and seeing if the participant (human or animal) can reel ...
Study finds that radiation oncology research is critically underfunded by NIH
2013-05-29
Radiation oncology research received 197 grants, totaling only 1.6 percent ($85.5 million) of the $5.4 billion in cancer research funding from the National Institutes of Health (NIH) in Fiscal Year (FY) 2013, according to a study available online and in the June 1, 2013, print issue of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).
The study reviewed the more than 50,000 grants funded by the NIH, totaling $30.9 billion. Investigation revealed 952 ...
Brain haemorrhage patients offered better treatment
2013-05-29
An international trial has provided surgeons with a formula which predicts when brain haemorrhage patients need surgery for the best outcome.
Brain haemorrhage affects some 4 million patients a year worldwide and the trial, run from Newcastle University, will help to ensure the best treatment is given at the right time.
David Mendelow, Professor of Neurosurgery at Newcastle University and honorary consultant within the Newcastle Hospitals NHS Foundation Trust, who ran the trials, has devised a formula published today in The Lancet online which will allow surgeons to ...
'Junk DNA' plays active role in cancer progression, researchers find
2013-05-29
Scientists at The University of Nottingham have found that a genetic rogue element produced by sequences until recently considered 'junk DNA' could promote cancer progression.
The researchers, led by Dr Cristina Tufarelli, in the School of Graduate Entry Medicine and Health Sciences, discovered that the presence of this faulty genetic element — known as chimeric transcript LCT13 — is associated with the switching off of a known tumour suppressor gene (known as TFPI-2) whose expression is required to prevent cancer invasion and metastasis.
Their findings, published online ...
Recovery of Hawaiian green sea turtles still short of historic levels, Stanford-led study suggests
2013-05-29
Calls to lift protections for the iconic Hawaiian green sea turtle may be premature, according to a new study led by a Stanford researcher.
Although the number of Hawaiian green sea turtles has increased since 1978 when the species was listed under the U.S. Endangered Species Act, the population may still be only a fraction of historic levels, the research shows.
"It's critical to compare the animal's population level to its historic abundance, not just to recent levels," said study coauthor John N. "Jack" Kittinger, an early career fellow at Stanford's Center for Ocean ...
Gene therapies for regenerative surgery are getting closer, says review in PRS
2013-05-29
Philadelphia, Pa. (May 29, 2013) – Experimental genetic techniques may one day provide plastic and reconstructive surgeons with an invaluable tool—the ability to promote growth of the patient's own tissues for reconstructive surgery. A review of recent progress toward developing effective gene therapies for use in "regenerative surgery" appears in the June issue of Plastic and Reconstructive Surgery®, the official medical journal of the END ...
Tobacco companies are not public health stakeholders
2013-05-29
When assessing information presented by the tobacco industry, the US regulator, the Food and Drug Administration (FDA) and regulatory bodies in other countries, should be aware that they are dealing with companies with a long history of intentionally misleading the public. They therefore should actively protect their public-health policies on smoking from the commercial interests of the tobacco industry and not consider the industry as a stakeholder, concludes a study by experts from the US and Germany published in this week's PLOS Medicine.
The researchers, led by Stanton ...
Psychotherapy's benefits for depression
2013-05-29
Treatments for depression that don't involve antidepressant drugs but rather focus on different forms of talking therapy (referred to as psychotherapeutic interventions) are all beneficial, with no one form of therapy being better than the others, according to a study by international researchers published in this week's PLOS Medicine.
These findings are important as they suggest that patients with depression should discuss different forms of non-drug therapy with their doctors and explore which type of psychotherapy best suits them.
The researchers, led by Jürgen Barth ...